AXL inhibition in treatment-resistant metastatic adenoid cystic carcinoma
Adenoid cystic carcinoma (ACC) presents a formidable challenge due to its slow growth, late-stage metastasis, and resistance to conventional therapies. Targeting the AXL receptor, implicated in aggressive tumor behavior and therapeutic resistance, offers a promising therapeutic avenue. Several studi...
Saved in:
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-06-01
|
Series: | Oral Oncology Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772906024003820 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|